0001144204-17-044223.txt : 20170818 0001144204-17-044223.hdr.sgml : 20170818 20170818172648 ACCESSION NUMBER: 0001144204-17-044223 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170313 FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAMAD AKHTAR CENTRAL INDEX KEY: 0001645047 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38114 FILM NUMBER: 171041753 MAIL ADDRESS: STREET 1: 332 BLEECKER STREET STREET 2: #239 CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 3 1 v473693_form3.xml FORM 3 X0206 3 2017-03-13 0 0001644963 AVENUE THERAPEUTICS, INC. ATXI 0001645047 SAMAD AKHTAR C/O AVENUE THERAPEUTICS, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 Common Stock (Restricted) 50000 D The 50,000 shares of restricted Common Stock will vest as follows: One-third on August 8, 2020, one-third on August 8, 2021 and one-third on August 8, 2022. /s/ Lucy Lu, M.D., Attorney-in-Fact 2017-08-18